Valuation: Cencora, Inc.

Market Cap 59.91B 306B 52.35B 48.31B 44.53B 83.93B 5,769B 85.79B 577B 227B 2,825B 225B 220B 9,726B P/E 2026 *
17.1x
P/E 2027 * 18.2x
Enterprise Value 64.29B 329B 56.18B 51.84B 47.79B 90.07B 6,191B 92.07B 620B 244B 3,032B 241B 236B 10,438B EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.18x
Free-Float
62.46%
Yield 2026 *
0.77%
Yield 2027 * 0.79%
1 day-0.32%
3 months-11.44%
6 months-24.40%
Current year-25.57%
Current year 665.32
Extreme 665.32
952.48
1 year 665.32
Extreme 665.32
960
3 years 430.43
Extreme 430.43
960
5 years 309.44
Extreme 309.44
960
10 years 181.9
Extreme 181.9
960
Manager TitleAgeSince
Chief Executive Officer 59 30/09/2024
Director of Finance/CFO 59 28/06/2026
Chief Tech/Sci/R&D Officer 50 03/11/2024
Director TitleAgeSince
Director/Board Member 75 15/05/2013
Director/Board Member 59 30/09/2024
Chairman 64 30/09/2025
Change 5-day change 1-year change 3-year change Capi.($)
-0.32%-.--% - - 59.91B
+1.87%+7.19%-18.59%-6.15% 175B
-0.43%-0.80%-7.15%-3.39% 106B
+0.66%+0.96%+37.64%+54.22% 51.95B
-1.10%+4.10%-11.56%-37.95% 43.58B
-3.21%-3.05% - - 33.65B
-1.71%+2.25%-8.63%-42.64% 29.58B
-1.16%+1.28%+69.87%-7.10% 25.31B
-1.49%+0.85%-3.43%-4.22% 21.23B
-0.91%+1.31%-2.44%-21.84% 20.68B
Average -0.78%+1.57%+6.96%-8.63% 56.43B
Weighted average by Cap. +0.02%+2.85%-2.49%-4.76%

Financials

2026 *2027 *
Net sales 337B 1,724B 294B 272B 250B 472B 32,447B 483B 3,248B 1,277B 15,891B 1,265B 1,238B 54,706B 358B 1,832B 313B 289B 266B 502B 34,486B 513B 3,452B 1,358B 16,890B 1,345B 1,315B 58,143B
Net income 3.47B 17.76B 3.03B 2.8B 2.58B 4.86B 334B 4.97B 33.46B 13.16B 164B 13.04B 12.75B 564B 2.98B 15.26B 2.61B 2.4B 2.22B 4.18B 287B 4.27B 28.74B 11.31B 141B 11.2B 10.95B 484B
Net Debt 4.38B 22.43B 3.83B 3.53B 3.26B 6.14B 422B 6.28B 42.25B 16.62B 207B 16.46B 16.1B 712B 5.36B 27.42B 4.68B 4.32B 3.98B 7.51B 516B 7.67B 51.65B 20.32B 253B 20.12B 19.68B 870B
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
307.90USD
Average target price
353.50USD
Spread / Average Target
+14.81%

Quarterly revenue - Rate of surprise